Business Context and Reporting Period
Company: IDEAYA Biosciences, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: May 10, 2021
Reporting Period: First quarter ended March 31, 2021
Context: The filing serves to announce the Company's financial results for the first quarter of 2021. The detailed results are contained in a press release furnished as Exhibit 99.1.
Key Financial Metrics
The provided text is a cover sheet for the Form 8-K and does not contain specific numerical data. Consequently, the following metrics are not available in this excerpt:
- Revenue
- Profit/Loss
- Cash Flow
- Margins
- Debt Levels
- Liquidity Position
Note: The filing text does not provide a clear value for any financial metric; these figures are located in the referenced Exhibit 99.1.
Material Changes
The filing text does not disclose specific material changes versus the prior comparable period. It only indicates that results for the quarter ended March 31, 2021, have been announced.
Guidance, Outlook, and Risks
Management Commentary: The filing references a press release (Exhibit 99.1) for the full announcement but does not include management commentary, guidance, or outlook within the text provided.
Risks and Contingencies: No specific risks or contingencies are detailed in this excerpt.
Unusual Items: None identified in the provided text.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated May 10, 2021) for actual revenue, net loss, and cash burn figures.
- Verify the Company's cash runway and liquidity position as of March 31, 2021.
- Check for any updates on clinical trial progress or regulatory milestones mentioned in the full press release.
- Confirm if the Company provided updated financial guidance for the full year 2021.